Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Q BioMed, SRI Enter ASD Collaboration
To provide formulation development, preclinical development, and early clinical manufacturing of QBM-001 for non-verbal or minimally verbal autistic children12.13.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Industry News | Solid Dosage/Semi-solids
Federal Equipment & Investor Group Purchase Pharma Campus
The 110 acre, 800,000 sq. ft. site's features & capabilities include solid dosage form, liquid manufacturing filling, distribution warehouse, and vault storage12.11.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery
Together using artificial intelligence and machine learning, will leverage InveniAI's AlphaMeld platform for further discovery12.11.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Biogen Licenses ALS Treatment from Ionis
Obtained worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB067 (IONIS-SOD1RX)12.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
VBI, Brii Bio Partner for Hepatitis B
Brii Bio paid VBI $11 million upfront, including a $4 million upfront payment & a $7 million equity investment at $3 a share12.06.18
-
Breaking News | Drug Discovery | Industry News | Information Technology
Merck KGaA, Cyclica in AI Screening Platform Pact
Augmented platform is being used to uncover novel targets that are modeled to interact with a small molecule12.06.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Icagen & Roche Partner for Neurological Therapy
Will develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders12.05.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Evotec & LEO Pharma Partner for Drug Discovery
To generate new leads against innovative targets for a range of dermatological conditions12.04.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
iDD Biotech Receives Second Milestone
Milstone was initiated after its partner, Genmab, started a Phase I/IIa trial of GEN102912.04.18
-
Drug Development | Drug Discovery | Industry News
Developing Translational Biologics for Brain Disorders
The future of CNS therapiesAntti Nurmi, Charles River Discovery Services, Kuopio, Finland 11.30.18
-
Drug Development | Drug Discovery | Information Technology
AI in Pharma: Transforming Data into Drugs
Jane Z. Reed of Linguamatics discusses the potential benefits and obstacles leveraging data through AIOnline Exclusives Kristin Brooks, Contract Pharma 11.29.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
TRACON & I-Mab Partner for Immuno-Oncology
TRACON to be responsible for the regulatory & clinical development of I-Mab's TJD5 & up to five of the BsAbs in North America11.29.18
-
Bio News | Breaking News | Drug Discovery | Industry News
WuXi NextCODE Invests $400M to Expand Precision Medicine Efforts in Ireland
Includes the acquisition of Genomics Medicine Ireland11.28.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
WuXi Biologics, ABL Bio Enter Development Deal
For up to 8 antibody therapeutics including ABL Bio’s biologics pipelines & collaboration programs between ABL Bio and I-Mab11.28.18
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D | Reader Showcase
Aji Bio-Pharma Introduces New ADC Mfg. Technology
AJICAP technology lets developers of ADCs to better control the location of payload conjugation to an antibody11.28.18
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Evelo, Merck Enter Clinical Trial Collaboration
To evaluate EDP1503 in combination with Keytruda, Merck’s anti-PD-1 therapy, in multiple cancer indications11.27.18
-
Bio News | cGMP Manufacture | Drug Development | Drug Discovery | Industry News
Lonza Talks Drug Product Services Expansion
Dr. Hanns-Christian Mahler, Head Drug Product Services at Lonza, spoke with Contract Pharma about the business unit at AAPSVideos
-
Breaking News | Drug Discovery | Industry News | Laboratory Testing
Vector Labs Attains ISO 9001:2015 Certification
Designation certifies a high level of quality assurance and consistency for research in pharmaceutical discovery11.14.18
